| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Swieringa John | PRES, TECH & COO | 9601 S. MERIDIAN BLVD., ENGLEWOOD | /s/ John Swieringa, by Dean A. Manson, Attorney-in-Fact | 2025-09-11 | 0001661534 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SATS | Class A Common Stock | Sale | -$2.22M | -27.3K | -98.44% | $81.24 | 432 | Sep 9, 2025 | Direct | F1 |
| transaction | SATS | Class A Common Stock | Options Exercise | $896K | +63.8K | +14777.78% | $14.04 | 64.3K | Sep 9, 2025 | Direct | |
| transaction | SATS | Class A Common Stock | Sale | -$5.18M | -63.8K | -99.33% | $81.20 | 432 | Sep 9, 2025 | Direct | F2 |
| transaction | SATS | Class A Common Stock | Options Exercise | $164K | +11.7K | +2707.41% | $14.04 | 12.1K | Sep 9, 2025 | Direct | |
| transaction | SATS | Class A Common Stock | Sale | -$949K | -11.7K | -96.44% | $81.18 | 432 | Sep 9, 2025 | Direct | F3 |
| transaction | SATS | Class A Common Stock | Options Exercise | $238K | +16.9K | +3920.37% | $14.04 | 17.4K | Sep 9, 2025 | Direct | |
| transaction | SATS | Class A Common Stock | Sale | -$1.37M | -16.9K | -97.51% | $81.18 | 432 | Sep 9, 2025 | Direct | F4 |
| transaction | SATS | Class A Common Stock | Options Exercise | $581K | +35.1K | +8121.99% | $16.57 | 35.5K | Sep 9, 2025 | Direct | |
| transaction | SATS | Class A Common Stock | Sale | -$2.85M | -35.1K | -98.78% | $81.20 | 432 | Sep 9, 2025 | Direct | F5 |
| holding | SATS | Class A Common Stock | 809 | Sep 9, 2025 | I | F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SATS | Employee Stock Option (Right To Buy) | Options Exercise | $0 | -63.8K | -70% | $0.00 | 27.4K | Sep 9, 2025 | Class A Common Stock | 63.8K | $14.04 | Direct | F7 |
| transaction | SATS | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -11.7K | -66.67% | $0.00 | 5.85K | Sep 9, 2025 | Class A Common Stock | 11.7K | $14.04 | Direct | F8 |
| transaction | SATS | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -16.9K | -25% | $0.00 | 50.8K | Sep 9, 2025 | Class A Common Stock | 16.9K | $14.04 | Direct | F9 |
| transaction | SATS | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -35.1K | -20% | $0.00 | 140K | Sep 9, 2025 | Class A Common Stock | 35.1K | $16.57 | Direct | F10 |
| Id | Content |
|---|---|
| F1 | Based on a weighted average sale price. The shares reported in this transaction were sold at prices ranging from $81.09 to $81.48. Information regarding the number of shares sold at each separate price will be made available upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer. |
| F2 | Based on a weighted average sale price. The shares reported in this transaction were sold at prices ranging from $80.88 to $81.45. Information regarding the number of shares sold at each separate price will be made available upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer. |
| F3 | Based on a weighted average sale price. The shares reported in this transaction were sold at prices ranging from $80.88 to $81.43. Information regarding the number of shares sold at each separate price will be made available upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer. |
| F4 | Based on a weighted average sale price. The shares reported in this transaction were sold at prices ranging from $80.89 to $81.43. Information regarding the number of shares sold at each separate price will be made available upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer. |
| F5 | Based on a weighted average sale price. The shares reported in this transaction were sold at prices ranging from $80.88 to $81.43. Information regarding the number of shares sold at each separate price will be made available upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer. |
| F6 | By 401(K). |
| F7 | 40% of the shares underlying these options vested immediately upon the grant date. The remaining 60% of the shares underlying these options vest 30% per year on each of April 1, 2025 and April 1, 2026. |
| F8 | The grant is subject to achievement of certain performance criteria prior to December 31, 2026 and will vest based on achievement of such criteria. The performance criteria are not tied to the market price of the Issuer's securities. The shares exercised and sold represent 100% of the vested shares at the time of sale. The remainder of the shares underlying the options remain subject to performance criteria. |
| F9 | The shares underlying these options vest 25% per year on each of April 1, 2025, April 1, 2026, April 1, 2027 and April 1, 2028. |
| F10 | The shares underlying these options vest 20% per year on each of January 1, 2025, January 1, 2026, January 1, 2027, January 1, 2028 and January 1, 2029. Pursuant to the Merger Agreement, at the Effective Time, each option to purchase Issuer Class A Common Stock held by the Reporting Person was converted into a corresponding award with respect to EchoStar Class A Common Stock. |